Yes it clearly minimizes the cytokine storm which is what tends to kill those infected with Covid, however, there is indications from prior studies before the CDC study that it also helps the body fight off Covid. Please wait for the CDCs findings to see whether this can be firmly confirmed or not.

Indeed. We will see what the FDA has to say on CYDYs trials on Covid and Cancer as well. One thing at a time I guess. One of their Covid studies just concluded and the FDA is supposed to issue a expected date on reviewing it this month.

This is very insightful and correct. During downturns people tend to stock paper money for the sense of security it brings and to deal with unexpected emergencies. Also noted is the fact that people are less likely to spend larger sums of money if they must use paper money.

I am hopeful at least a cure to help prevent Corona from killing people will come sooner rather than later. We will see if CytoDyn is a success very soon because they are first in line with FDA trials, one which rapped up recently and needs a formal review. There is also many drugs hoping to be a cure.

This nightmare will come to an end using science. The best many of us can do to help it is to financially support those seeking a solution, donating blood, and/or donating to those helping to treat or aid those suffering from the disease.

Indeed we are looking at a change in economics. I believe that we have moved beyond Keynes and are now looking into a great leap more akin to dealing with the problems and solutions in the "The Affluent Society" by Harvard economist John Kenneth Galbraith. How we do this while remaining firmly tied to capitalism is yet to be seen. For one thing we must remain a consumer driven society so a universal basic income sure beats a command economy where government manufactures jobs and the economy by supporting specific businesses to create jobs.

We need demand not supply to remain steady and balanced. We will see what the future hold. Hopefully it will be better than before.

Yes Cytodyn has a lot going on right now. I agree, this stock is for long term holders, that is why the article's main focus is on the science. A lot of the hype has been put in only about its Corona treatment which can be a big market now. However, long term holders still have their eyes on Cancer and HIV.

What I posted in the reply was not my words it was from Cytodyn's website from their press release. If you disagree please contact them for their wording. Let me know if they are wrong.

It is on their website.

About Leronlimab (PRO 140)

The FDA has granted a “Fast Track” designation to CytoDyn for two potential indications of leronlimab for deadly diseases. The first as a combination therapy with HAART for HIV-infected patients and the second is for metastatic triple-negative breast cancer. Leronlimab is an investigational humanized IgG4 mAb that blocks CCR5, a cellular receptor that is important in HIV infection, tumor metastases, and other diseases, including NASH. Leronlimab has completed nine clinical trials in over 800 people, including meeting its primary endpoints in a pivotal Phase 3 trial (leronlimab in combination with standard antiretroviral therapies in HIV-infected treatment-experienced patients).

www.cytodyn.com/.../cytodyn-submits-completed-biologics-license-application

The process to get a PDUFA dates usually take up to 10 months or longer. This has been placed in the head of the line which is usually 6 months. Thus if it gets a PDUFA date anything shorter it is being fast tracked by definition.

Is this affected by the meat cutting and packaging Covid problems? It hasn't done well last year. Is there something new about this stock? Otherwise it looks like it's going to continue to sit around.